Cat or Dog Ownership and Seroprevalence of Ehrlichiosis, Q Fever, and Cat-Scratch Disease by Skerget, Martina et al.
Cat or Dog
Ownership and
Seroprevalence 
of Ehrlichiosis,
Q Fever, and Cat-
Scratch Disease 
Martina Skerget,* Christoph Wenisch,* 
Florian Daxboeck,† Robert Krause,* 
Renate Haberl,* and Doris Stuenzner* 
Concerns have been raised about the role of domestic
cats or dogs in the acquisition of zoonoses, in particular in
pregnant women or immune-suppressed persons. We
report that cat or dog ownership is not associated with an
increased seroprevalence of antibodies to Anaplasma
phagozytophilum, Coxiella burnetii, and Bartonella hense-
lae in symptom-free persons in Styria, Austria. 
K
eeping pet cats and dogs is very popular in Austria.
However, these animals can serve as reservoirs for the
agents of important bacterial infectious diseases and as a
potential source of infection for humans, even though the
infectious animals may be asymptomatic. Infections are
potentially transmitted from domestic animals to humans
by scratches, bites, or close contact. Examples for such
infections include human granulocytic ehrlichiosis
(Anaplasma  phagocytophilum), cat-scratch disease (CSD,
Bartonella henselae), and Q fever (Coxiella burnetii).
Cats are known to be the most important source of
infections for B. henselae (aeroprevalence in Austrian cats
is 33%) (1). However, dogs may also transmit B. henselae
(2). Animals are contagious through their blood, which
may contaminate saliva in cases of gum bleeding. Fleas
from infected animals may contain the infectious agent,
and bites from these fleas can transmit CSD. Typically,
CSD is a benign and self-limiting disease in humans,
occurring with lymphadenopathy, low-grade fever, pri-
mary cutaneous inoculation lesion, and weight loss, lasting
6–12 weeks. Rarely observed atypical signs and symptoms
include erythema nodosum, figurate erythemas, thrombo-
cytopenic purpura, Perinaud’s oculoglandular syndrome,
encephalopathy, hepatic granulomas, osteomyelitis, pul-
monary disease, and optic neuritis (3). These severe mani-
festations occur in immunocompetent patients, whereas
bacillary angiomatosis or peliosis hepatitis are more likely
to develop in immunosuppressed patients. 
C. burnetii infection has been associated with a chron-
ic fatigue–like syndrome (4). Both cats and dogs are well-
described reservoirs for C. burnetii (5). In humans, C. bur-
netii infection usually is asymptomatic (60%) or manifests
as a mild disease with fever, headache, myalgias, and
spontaneous recovery (5). However, this infection may
lead to serious complications and even death in patients
with acute disease, especially those with meningoen-
cephalitis and myocarditis and, more frequently, in chron-
ically infected patients with endocarditis. Q fever in preg-
nancy has been associated with abortion, premature birth,
and low weight in newborns (6,7).
Within the past several decades, the number of
Ehrlichia and Anaplasma spp. recognized to infect cats,
dogs, and humans has expanded substantially (8). The
agent of human granulocytic ehrlichiosis (HGE) has
recently been classified as A. phagozytophilum (9). The
disease has influenzalike symptoms with variable degrees
of anemia, thrombocytopenia, leukopenia, and elevated
liver enzymes. Dogs are thought to be sentinels for assess-
ing risk for HGE in humans (10). Cases of HGE in the
United States are increasing in incidence (11). Reports of
acute cases in Europe have been rare, although serosurveys
of the prevalence of antibodies to A. phagocytophilum
have been conducted. A survey in Slovenia showed that
15.4% of the examined population had detectable antibod-
ies to the pathogen and several cases of HGE had been
confirmed (12). No similar serosurvey has been conducted
in Austria, although Ixodes ricinus, thought to be the prin-
cipal vector in Europe, is present in Austria (13). We report
that the rate of seropositivity of A. phagocytophilum
(immunoglobulin [Ig] G antibodies 25/376 [7%], IgM anti-
bodies 6/376 [2%]), B. henselae (88/376 [23%]), and C.
burnetii (23/376 [6%]) in Styria, Austria, is not affected by
cat or dog ownership. 
The Study
We examined serum specimens from 376 persons that
were collected at the University Hospital Graz, Austria,
from December 2001 to April 2002. These persons had no
history of a tick bite for at least 1 year. A total of 202 per-
sons with domestic dogs, cats, or both (dogs n=77, cats
n=106, dogs and cats n=19) were compared with 174 per-
sons who had no domestic pet contact for at least 1 year.
Study participants in the no-pet group had never lived with
a cat or a dog. The domestic pets had no symptoms or signs
of infection, as determined by veterinarians. All partici-
pants were outpatients, and blood samples were drawn for
routine blood tests. Each participant completed a question-
naire about medical history. These persons had no known
history of rickettsiosis, borreliosis, or tick-borne
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Vienna, Austriaencephalitis and reported no febrile or influenzalike illness
during the previous 6 months. Each participant provided
verbal consent for the serum to be used for detecting anti-
bodies against several infectious agents related to
zoonoses. The following information was collected for
each participant: age, sex, area of residence, and medical
history. Demographic data for the participants are shown
in Table 1.
Serum samples were tested for the infectious agents
with the following methods: B. henselae by indirect
immunofluorescence (Biognost, Gräfelfing, Germany), C.
burnetii by microagglutination reaction (Bodybion Mar;
Bioveta National Enterprise Nitra, Slovakia), and HGE
IgM indirect immunofluorescent antibody test (IFA, MRL
Diagnostics, Cypress, CA), HGE by IFA IgG (Focus
Technologies, Cypress, CA) with titers >64 were consid-
ered positive. All assays were performed in duplicate
according to manufacturers’ instructions. Biostatistical
analysis was performed with the statistical package Jandel
SigmaStat Statistical Software, version 2.0, NL (Jandel
SigmaStat, Jandel, San Rafael, CA). Chi-square tests or t
tests were used to determine differences between the pres-
ence of antibodies to the test organisms and demographic
data, as appropriate. A two-tailed p value <0.05 was con-
sidered significant.
A total of 88 (23%) of 376 persons had antibodies
against B. henselae. No differences in terms of age, sex,
urban or rural residence, or concomitant diseases were
noted. No difference in persons with and without domestic
pets (46/174 [26%] and 42/202 [20%], respectively) was
seen (Table 2).
The overall prevalence of antibodies to C. burnetii was
6% (23/376 persons). Again, no differences in age, sex,
urban or rural residence, or concomitant diseases (13/202
[6%]) and persons with and without domestic pets (10/174
[6%]), were seen (Table 2).
The overall prevalence of IgG/IgM antibodies to A.
phagocytophilum was 7% and 2% (25/376, and 6/376,
respectively). No differences in terms of age, sex, urban or
rural residence, or concomitant diseases were seen. IgG
antibody titers were low (of 25 positive serum specimens,
17 had titers >64, and 8 had titers >128). In the six patients
with positive IgM antibodies, no clinical evidence of ehrli-
chiosis was present, and additional blood samples showed
no cytopenia. No difference in persons with (8% and 2%
IgG/IgM positive, respectively) and without domestic pets
(6% and 1% IgG/IgM positive, respectively) was seen
(Table 2).
The seroreactivity to C. burnetii and B. henselae did not
differ between A. phagocytophilum–positive patients and
A. phagocytophilum–negative patients (p>0.05). Likewise,
the seroreactivity to A. phagocytophilum and B. henselae
did not differ between C. burnetii–positive patients and C.
burnetii–negative patients (p>0.05). In addition, the
seroreactivity to A. phagocytophilum and C. burnetii did
not differ between B. henselae–positive patients and B.
henselae–negative patients (p>0.05). 
Conclusions
Veterinarians have the responsibility of providing accu-
rate information to their clients about the zoonotic trans-
mission of infections from pets, especially to those most
vulnerable, such as children, pregnant women, the elderly,
and the immunocompromised. Effective education is vital
to allay public concerns and promote responsible pet own-
ership (14). With respect to A. phagocytophilum, B. hense-
lae, and C. burnetii, cat or dog ownership was not related
to an increased incidence of antibodies in our study. 
CSD has been reported worldwide and seemsto be the
most common B. henselae infection in humans. In the
United States, epidemiologic databases estimate that
approximately 24,000 cases of CSDoccur each year, with
a calculated incidence of 9.3/10,000 ambulatory patients
per year. In various studies, the seroprevalence of antibod-
ies to B. henselae in humans ranges from 3.6% to 6%
(15–17). Although CSD may occur in persons of any age,
most patients are <18 years of age, perhaps because chil-
dren aremore likely to have close and rough contact with
cats. The observed high incidence of antibody positivity in
adults could be related to the persistence of antibodies after
asymptomatic infection. Alternatively, it may be due
chronic low-grade infection, which has been demonstrated
for B. quintana and B. bacilliformis (18,19). The incidence
of CSD is seasonal; most cases occur in August to October
in northern temperate areas. The prevalence of the disease
also varies by geographic location. The prevalence of anti-
bodies to B. henselae is reportedly higher in areas with
warm humid climates, where the prevalence and intensity
of cat flea infestations are higher (20). Cats may infect
humans either directly through scratches andbites or indi-
rectly by means of the cat flea (Ctenocephalides felis),
which is the arthropod vector (20). Recent research has
demonstrated that B. henselae seroprevalence is elevated
in patients with coronary vascular disease (21).
Considering the comparatively high mean age of the
patients tested in this study and the high percentage of
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Table 1. Demographic data of patients with and without domestic pets 
  No pet (n=174)  Cat (n=106)  Dog (n=77)  Cat and dog (n=19) 
Age (y)  55±19  51±14  53±20  55±15 
Sex (male/female)  55/119  32/74  37/38  6/13 
Urban/rural  133/41  63/43  39/36  7/12 patients admitted for cardiovascular disease (Table 1), our
results provide indirect support for this finding.
Because Q fever is rarely a notifiable disease, its inci-
dence in humans cannot be assessed in most countries.
Current epidemiologic studies indicate, however, that Q
fever should be considered a public health problem in
many countries, including France, United Kingdom, Italy,
Spain, Germany, Israel, Greece, and Canada (Nova
Scotia), as well as in many countries where Q fever is
prevalent but unrecognized because of poor surveillance.
Q fever remains primarily an occupational hazard in per-
sons in contact with domestic animals such as cattle,
sheep, and, less frequently, goats. Persons at risk from Q
fever include farmers, veterinarians, abattoir workers,
those in contact with dairy products, and laboratory per-
sonnel performing C. burnetiiculture and working with C.
burnetii–infected animals. However, reports of sporadic
cases in persons living in urban areas after occasional con-
tact with farm animals or after contact with infected pets
such asdogs andcats have increased. Our data suggest that
Q fever also occurs in Austria but that pet ownership or
rural residence has no effect on seroprevalence. C. burnetii
has also been isolated from the locally widespread I. rici-
nus ticks (22), although no tick-borne Q fever has been
described in Austria.
For A. phagocytophilum, our seroprevalence is similar
to those observed in Greece, much lower than that in
Slovenia (15.4%), and higher than those seen in Bulgaria
(2.9%) and Germany (1.9%) (23). In Austria (Styria), the
prevalence in blood donors is 4% (24). We agree with
Daniel et al. (23) that this Austrian prevalence could be
due to the fact that the prevalence in blood donors is lower,
unlike the survey in Greece, Slovenia, or this assessment.
Even though the titers to A. phagocytophilum were low in
our study, they suggest infection at an undetermined time.
Our data also suggest a discrepancy between the com-
paratively high seroprevalence of specific antibodies to A.
phagozytophilum, C. burnetii, and B. henselae, respective-
ly, and the few diagnosed cases of human disease. Clearly,
cat or dog ownership is not related to an increased inci-
dence of antibodies against these pathogens. However,
because of the widespread distribution of I. ricinus, an
organism also capable of transmission, this finding must
be interpreted cautiously. In addition, the small sample size
may have been insufficient to detect differences between
the groups. Hence, recommendations for the population at
risk for a severe course of these infections (pregnant
women, the elderly, immunosuppressed patients, HIV-pos-
itive persons, and infants) are not possible. Nonetheless,
such groups of patients may benefit from efficient tick and
flea control on dogs and cats, as an adjunct to decrease
mechanical transport of the parasites into their homes.
Further research is needed to clarify the importance of pets
or ticks for these diseases in Austria. 
Dr. Skerget is a research fellow at the Department of
Medicine, University of Graz. She is interested in zoonoses.
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No pet  
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Cat 
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Dog 
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Cat and dog 
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No pet/cat 
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No pet/dog 
p value 
No pet/cat and 
dog p value 
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bIg, immunoglobulin. 
 10. Foley JE, Foley P, Madigan JE. Spatial distribution of seropositivity
to the causative agent of granulocytic ehrlichiosis in dogs in
California. Am J Vet Res 2001;62:1599–605.
11. Ijdo JW, Meek JI, Cartter ML, Magnarelli LA, Wu C, Tenuta SW, et
al. The emergence of another tickborne infection in the 12-town area
around Lyme, Connecticut: human granulocytic ehrlichiosis. J Infect
Dis 2000;181:1388–93.
12. Cizman M, Avsic-Zupanc T, Petrovec M, Ruzic-Sabljic E, Pokorn M.
Seroprevalence of ehrlichiosis, Lyme borreliosis and tick borne
encephalitis infections in children and young adults in Slovenia. Wien
Klin Wochenschr 2000;112:842–5.
13. Sixl W, Hinaidy HK, Kutzer E. Tick fauna of Austrian carnivores.
Wiener Tierärztliche Monatsschrift 1971;58:427.
14. Rehacek J, Kaaserer B, Urvolgyi J, Lukacova M, Kovacova E,
Kocianova E. Isolation of Coxiella burnetii and of an unknown
rickettsial organism from Ixodes ricinus ticks collected in Austria.
Eur J Epidemiol 1994;10:719–23.
15. Zangwill KM, Hamilton DH, Perkins BA, Regnery RL, Plikaytis BD,
Hadler JL, et al. Cat scratch disease in Connecticut: epidemiology,
risk factors, and evaluation of a new diagnostic test. N Engl J Med
1993;329:8–13.
16. Jackson LA, Perkins BA, Wenger JD. Cat-scratch disease in the
United States: an analysis of three national databases. Am J Public
Health 1993;83:1707–11. 
17. Hamilton DH, Zangwill KM, Hadler JL, Carter ML. Cat-scratch
disease—Connecticut, 1992–1993. J Infect Dis 1995;172:570–3.
18. Kosek M, Lavarello R, Gilman RH, Delgado J, Maguina C,
Verastegui M, et al. Natural history of infection with Bartonella
bacilliformis in a nonendemic population. J Infect Dis
2000;182:865–72.
19. Foucault C, Barrau K, Brouqui P, Raoult D. Bartonella quintana
bacteremia among homeless people. Clin Infect Dis 2002;35:684–9.
20. Irwin PJ. Companion animal parasitology: a clinical perspective. Int
J Parasitol 2002;32:581–93.
21. Ender PT, Phares J, Gerson G, Taylor SE, Regnery R, Challener RC,
et al. Association of Bartonella species and Coxiella burnetii infec-
tion with coronary artery disease: J Infect Dis 2001;183:831–4.
22. Jacomo V, Kelly PJ, Raoult D. Natural history of Bartonella
infections (an exception to Koch’s postulate). Clin Diagn Lab
Immunol 2002;9:8–18.
23. Daniel SA, Manika K, Arvanitidou M, Diza E, Symeonidis N,
Antoniadis A. Serological evidence of human granulocytic ehrlichio-
sis, Greece. Emerg Infect Dis 2002;8:643–4. 
24. Sixl W, Ladurner G, Stuenzner D, Marth E. Epidemiological exami-
nations of human sera for Ehrlichia in Austria. International
Conference on Lyme Borreliosis and other Emerging Tick-Borne
Diseases. Jun 20–24, 1999. Munich, Germany. Abstract book. Basel,
Switzerland: AKM Congress Service; 1999. p. 55.
Address for correspondence: Christoph Wenisch, Division of Infectious
Diseases, Department of Medicine, University Hospital Graz,
Auenbruggerplatz 15, A-8036 Graz, Austria; fax: +43-316-385-4622;
email: christoph.wenisch@uni-graz.at
1340 Emerging Infectious Diseases • Vol. 9, No. 10, October 2003
DISPATCHES
S Se ea ar rc ch h   p pa as st t   i is ss su ue es s   o of f   E EI ID D   a at t   w ww ww w. .c cd dc c. .g go ov v/ /e ei id d